Intensity, duration of drug shortages are spiking, FDA says

(By Alia Paavola for Becker’s Hospital Review)

The FDA is not only seeing an increased incidence of drug shortages,  there’s also been a jump in the intensity and duration of the shortages, according to Regulatory Focus. Continue reading article here…

 

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

 

Leave a Reply